Evidence map›Paper›PMID 39530100›Full record

ReviewFrontiers in immunology2024

The chosen few:

Sasha E Larsen, Hazem F M Abdelaal, Courtney R Plumlee, Sara B Cohen, Ho D Kim, Holly W Barrett, Qingyun Liu, Matthew H Harband, Bryan J Berube, Susan L Baldwin and 3 more

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Modulation of Ferroptosis During EarlybioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Transcript-Capture sequencing enriches mRNA ofbioRxiv : the preprint server for biology · 2025
    Article
  5. Virulence hierarchies within theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sasha E LarsenSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Hazem F M AbdelaalSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Courtney R PlumleeSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Sara B CohenSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Ho D KimSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Holly W BarrettSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Qingyun LiuDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Matthew H HarbandSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Bryan J BerubeSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Susan L BaldwinSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Sarah M FortuneDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, United States.
Kevin B UrdahlSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.
Rhea N ColerSeattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)75N93019C00071 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI FORTUNE, SARAH · 2019 to 2025
$57.3M
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)75N93021C00029 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI COLER, RHEA · 2022 to 2025
$35.2M
Understanding the Function of F13 as a Matrix Protein for Poxvirus Intracellular EnvelopmentR01AI168023 · NIAID · UNIVERSITY OF ROCHESTER · PI BRIAN M WARD · 2023 to 2026
$1.5M
NIAID NIH HHS 75N93019C00070NIAID NIH HHS 75N93019C00071NIAID NIH HHS 75N93021C00029NIAID NIH HHS R01 AI168023
6 · The paper itself

Abstract

The three programs that make up the Immune Mechanisms of Protection Against

Indexed as

Mycobacterium tuberculosisTuberculosisGenome, BacterialHost-Pathogen InteractionsHumansVirulencediversityIMPAc-TBisolateslineagesMycobacterium tuberculosisTBtuberculosis

Identifiers

PMID39530100
PMCPMC11551615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.